Hemolytic Anemia

Also known as: Haemolytic anemia / Haemolytic anaemia / Anaemia haemolytic / Haemolytic anaemia NOS / Anemia hemolytic (NOS) / Hemolytic anemia (NOS) / Anemia, Hemolytic / Hemolytic anemia (disorder) / Anemia hemolytic

Drug	Drug Name	Drug Description
DB00297	Bupivacaine	A local anesthetic used in a wide variety of superficial and invasive procedures.
DB14975	Voxelotor	A drug used to inhibit the polymerization of hemoglobin S, preventing the painful and sometimes lethal vaso-occlusive crises associated with sickle cell disease.

Drug	Drug Name	Target	Type
DB00297	Bupivacaine	Sodium channel protein type 10 subunit alpha	target
DB00297	Bupivacaine	Prostaglandin E2 receptor EP1 subtype	target
DB00297	Bupivacaine	Cytochrome P450 3A4	enzyme
DB00297	Bupivacaine	Cytochrome P450 2C19	enzyme
DB00297	Bupivacaine	Cytochrome P450 2D6	enzyme
DB14975	Voxelotor	Cytochrome P450 3A4	enzyme
DB14975	Voxelotor	Cytochrome P450 2C9	enzyme
DB14975	Voxelotor	Cytochrome P450 2B6	enzyme
DB14975	Voxelotor	Cytochrome P450 2C19	enzyme
DB14975	Voxelotor	Hemoglobin subunit alpha	target

Drug	Drug Name	Phase	Status	Count
DB09331	Daratumumab	1	Active Not Recruiting	1
DB14740	Hyaluronidase	1	Active Not Recruiting	1
DB16236	Mitapivat	1 / 2	Active Not Recruiting	1
DB00091	Cyclosporine	2	Unknown Status	2
DB01609	Deferasirox	2	Completed	1
DB00746	Deferoxamine	2	Completed	1
DB00848	Levamisole	2	Unknown Status	3
DB00860	Prednisolone	2	Unknown Status	1
DB00635	Prednisone	2	Unknown Status	1
DB16236	Mitapivat	3	Completed	2
DB00811	Ribavirin	3	Completed	1
DB16236	Mitapivat	4	Enrolling by Invitation	1
DB00028	Human immunoglobulin G	Not Available	Completed	1